肿瘤靶向-话题@MedSci - 梅斯（MedSci）

#肿瘤靶向#

29篇内容 | 1688人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1948496, encodeId=dff9194849618, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=CD39-CD73-腺苷: 针对免疫微环境的肿瘤靶向治疗, objectType=article, longId=737934, objectId=f5a2e379344e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5a2e379344e, replyNumber=0, likeNumber=113, createdTime=2022-11-12, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5a2e379344e, moduleTitle=CD39-CD73-腺苷: 针对免疫微环境的肿瘤靶向治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f5a2e379344e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948495, encodeId=9fa4194849593, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=远程胆胰管内镜下激光肿瘤靶向治疗打响“胰腺保卫战”, objectType=article, longId=737682, objectId=0ddae3768229, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ddae3768229, replyNumber=0, likeNumber=152, createdTime=2023-05-24, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ddae3768229, moduleTitle=远程胆胰管内镜下激光肿瘤靶向治疗打响“胰腺保卫战”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ddae3768229)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948494, encodeId=ee27194849468, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=Cell Reports丨余发星课题组报道Hippo通路细胞表面调控元件及肿瘤靶向治疗策略, objectType=article, longId=737486, objectId=80cde374863a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80cde374863a, replyNumber=0, likeNumber=128, createdTime=2023-04-26, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80cde374863a, moduleTitle=Cell Reports丨余发星课题组报道Hippo通路细胞表面调控元件及肿瘤靶向治疗策略, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=80cde374863a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948493, encodeId=855b1948493ec, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=Blood：肿瘤靶向纳米颗粒可改善BCL2和MCL1双重抑制的治疗效果, objectType=article, longId=202288, objectId=af35202288ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af35202288ff, replyNumber=0, likeNumber=80, createdTime=2021-03-29, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af35202288ff, moduleTitle=Blood：肿瘤靶向纳米颗粒可改善BCL2和MCL1双重抑制的治疗效果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=af35202288ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948492, encodeId=03e61948492db, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=Nat Commun | 发表肿瘤靶向新机制：助力癌症精准诊疗！, objectType=article, longId=182461, objectId=e73f1824616f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e73f1824616f, replyNumber=0, likeNumber=84, createdTime=2020-08-06, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e73f1824616f, moduleTitle=Nat Commun | 发表肿瘤靶向新机制：助力癌症精准诊疗！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e73f1824616f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948491, encodeId=6958194849199, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=teriflunomide联合肿瘤靶向疗法可能会改善胶质母细胞瘤的治疗结果, objectType=article, longId=177483, objectId=e98e1e74838c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e98e1e74838c, replyNumber=0, likeNumber=0, createdTime=2020-02-01, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e98e1e74838c, moduleTitle=teriflunomide联合肿瘤靶向疗法可能会改善胶质母细胞瘤的治疗结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e98e1e74838c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948488, encodeId=2ef619484885d, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=妇科肿瘤靶向治疗三大热点药物, objectType=article, longId=152435, objectId=24b11524354f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24b11524354f, replyNumber=0, likeNumber=104, createdTime=2019-08-24, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24b11524354f, moduleTitle=妇科肿瘤靶向治疗三大热点药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=24b11524354f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948489, encodeId=0a81194848966, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=ACS Appl Mater Interfaces：发现新一代肿瘤靶向药物载体, objectType=article, longId=159955, objectId=3dd515995591, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dd515995591, replyNumber=0, likeNumber=80, createdTime=2019-09-11, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dd515995591, moduleTitle=ACS Appl Mater Interfaces：发现新一代肿瘤靶向药物载体, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3dd515995591)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948490, encodeId=451819484908d, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=Sci Rep：前列腺癌中白蛋白结合的肿瘤靶向前体药物研究, objectType=article, longId=161403, objectId=0d7a16140388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d7a16140388, replyNumber=0, likeNumber=132, createdTime=2019-11-11, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d7a16140388, moduleTitle=Sci Rep：前列腺癌中白蛋白结合的肿瘤靶向前体药物研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0d7a16140388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948483, encodeId=ace41948483bc, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=NPG Asia Materials：二维纳米材料肿瘤靶向放疗研究获进展, objectType=article, longId=119362, objectId=365d11936257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=365d11936257, replyNumber=0, likeNumber=136, createdTime=2018-03-08, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=365d11936257, moduleTitle=NPG Asia Materials：二维纳米材料肿瘤靶向放疗研究获进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=365d11936257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948481, encodeId=f4f21948481eb, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=天津血液肿瘤高峰论坛 | 肖志坚教授：骨髓增殖性肿瘤靶向治疗进展, objectType=article, longId=119097, objectId=650211909e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=650211909e0b, replyNumber=0, likeNumber=149, createdTime=2018-03-26, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=650211909e0b, moduleTitle=天津血液肿瘤高峰论坛 | 肖志坚教授：骨髓增殖性肿瘤靶向治疗进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=650211909e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948487, encodeId=a588194848e2a, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=Nat Genet：近10000例前瞻性肿瘤靶向测序，MSK-IMPACT揭示近30％的肿瘤存在全基因组倍增（WGD）, objectType=article, longId=144616, objectId=6981144616a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6981144616a0, replyNumber=0, likeNumber=136, createdTime=2018-10-23, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6981144616a0, moduleTitle=Nat Genet：近10000例前瞻性肿瘤靶向测序，MSK-IMPACT揭示近30％的肿瘤存在全基因组倍增（WGD）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6981144616a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948486, encodeId=d70f194848676, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=Nat Commun：新型肿瘤靶向抗体偶联药物有效治疗结肠癌和卵巢癌, objectType=article, longId=138147, objectId=35eb13814ed9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35eb13814ed9, replyNumber=0, likeNumber=85, createdTime=2018-09-26, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35eb13814ed9, moduleTitle=Nat Commun：新型肿瘤靶向抗体偶联药物有效治疗结肠癌和卵巢癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=35eb13814ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948485, encodeId=0c851948485e9, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=NPG Asia Mater：深圳先进院二维材料肿瘤靶向放疗研究获进展, objectType=article, longId=119420, objectId=ef5711942088, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef5711942088, replyNumber=0, likeNumber=106, createdTime=2018-09-18, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef5711942088, moduleTitle=NPG Asia Mater：深圳先进院二维材料肿瘤靶向放疗研究获进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ef5711942088)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948477, encodeId=914019484e7f1, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=Small：程序化纳米制剂，自我协同的肿瘤靶向治疗, objectType=article, longId=100265, objectId=2bd5100265e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bd5100265e9, replyNumber=0, likeNumber=127, createdTime=2018-03-15, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bd5100265e9, moduleTitle=Small：程序化纳米制剂，自我协同的肿瘤靶向治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2bd5100265e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948484, encodeId=38291948484b7, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=【2017中国抗癌协会肿瘤靶向治疗专业委员会年会】徐瑞华教授：FRESCO研究造福中国患者，靶向与免疫治疗的结合拭目以待, objectType=article, longId=119394, objectId=9f231193943d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f231193943d, replyNumber=0, likeNumber=137, createdTime=2018-08-31, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f231193943d, moduleTitle=【2017中国抗癌协会肿瘤靶向治疗专业委员会年会】徐瑞华教授：FRESCO研究造福中国患者，靶向与免疫治疗的结合拭目以待, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f231193943d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948482, encodeId=a3d01948482ac, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=【2017中国抗癌协会肿瘤靶向治疗专业委员会年会】袁响林教授：肿瘤综合治疗已成趋势，多瘤种靶向治疗大放异彩, objectType=article, longId=119231, objectId=f0d71192319a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0d71192319a, replyNumber=0, likeNumber=123, createdTime=2018-06-16, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0d71192319a, moduleTitle=【2017中国抗癌协会肿瘤靶向治疗专业委员会年会】袁响林教授：肿瘤综合治疗已成趋势，多瘤种靶向治疗大放异彩, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f0d71192319a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948473, encodeId=ca4f19484e3d6, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=Sci Transl Med：我国科学家设计出新型肿瘤靶向治疗策略和抗体药物, objectType=article, longId=94787, objectId=1f6994e8726, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f6994e8726, replyNumber=0, likeNumber=103, createdTime=2018-01-18, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f6994e8726, moduleTitle=Sci Transl Med：我国科学家设计出新型肿瘤靶向治疗策略和抗体药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1f6994e8726)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948479, encodeId=55f119484e971, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=来那度胺等肿瘤靶向药拟纳入医保, objectType=article, longId=108098, objectId=caec10809882, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=caec10809882, replyNumber=0, likeNumber=82, createdTime=2017-11-01, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=caec10809882, moduleTitle=来那度胺等肿瘤靶向药拟纳入医保, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=caec10809882)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948480, encodeId=833a194848026, content=<a href='/topic/show?id=8d388313290' target=_blank style='color:#2F92EE;'>#肿瘤靶向#</a>, objectTitle=名家访谈 “艾”聚中原---外科专家热议阿帕替尼在消化道肿瘤靶向治疗的地位, objectType=article, longId=114415, objectId=2b44114415ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b44114415ea, replyNumber=0, likeNumber=101, createdTime=2018-06-23, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b44114415ea, moduleTitle=名家访谈 “艾”聚中原---外科专家热议阿帕替尼在消化道肿瘤靶向治疗的地位, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2b44114415ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤靶向

2020-05-29

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

CD39-CD73-腺苷: 针对免疫微环境的肿瘤靶向治疗

2022-11-12

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

远程胆胰管内镜下激光肿瘤靶向治疗打响“胰腺保卫战”

2023-05-24

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

Cell Reports丨余发星课题组报道Hippo通路细胞表面调控元件及肿瘤靶向治疗策略

2023-04-26

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

Blood：肿瘤靶向纳米颗粒可改善BCL2和MCL1双重抑制的治疗效果

2021-03-29

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

Nat Commun | 发表肿瘤靶向新机制：助力癌症精准诊疗！

2020-08-06

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

teriflunomide联合肿瘤靶向疗法可能会改善胶质母细胞瘤的治疗结果

2020-02-01

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

妇科肿瘤靶向治疗三大热点药物

2019-08-24

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

ACS Appl Mater Interfaces：发现新一代肿瘤靶向药物载体

2019-09-11

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

Sci Rep：前列腺癌中白蛋白结合的肿瘤靶向前体药物研究

2019-11-11

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

NPG Asia Materials：二维纳米材料肿瘤靶向放疗研究获进展

2018-03-08

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

天津血液肿瘤高峰论坛 | 肖志坚教授：骨髓增殖性肿瘤靶向治疗进展

2018-03-26

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

Nat Genet：近10000例前瞻性肿瘤靶向测序，MSK-IMPACT揭示近30％的肿瘤存在全基因组倍增（WGD）

2018-10-23

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

Nat Commun：新型肿瘤靶向抗体偶联药物有效治疗结肠癌和卵巢癌

2018-09-26

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

NPG Asia Mater：深圳先进院二维材料肿瘤靶向放疗研究获进展

2018-09-18

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

Small：程序化纳米制剂，自我协同的肿瘤靶向治疗

2018-03-15

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

【2017中国抗癌协会肿瘤靶向治疗专业委员会年会】徐瑞华教授：FRESCO研究造福中国患者，靶向与免疫治疗的结合拭目以待

2018-08-31

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

【2017中国抗癌协会肿瘤靶向治疗专业委员会年会】袁响林教授：肿瘤综合治疗已成趋势，多瘤种靶向治疗大放异彩

2018-06-16

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

Sci Transl Med：我国科学家设计出新型肿瘤靶向治疗策略和抗体药物

2018-01-18

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

来那度胺等肿瘤靶向药拟纳入医保

2017-11-01

yige2004 (审核中...)

前往app查看评论内容

#肿瘤靶向#

名家访谈 “艾”聚中原---外科专家热议阿帕替尼在消化道肿瘤靶向治疗的地位

2018-06-23

科室
- - 订阅+
  - 更多科室
工具
服务